Literature DB >> 19681165

Single-needle laser treatment with drainage of hydrothorax in fetal bronchopulmonary sequestration with hydrops.

R S G M Witlox1, E Lopriore, F J Walther, E R V M Rikkers-Mutsaerts, F J C M Klumper, D Oepkes.   

Abstract

Bronchopulmonary sequestration (BPS) is sometimes associated with hydrothorax and hydrops in utero. In the absence of fetal hydrops, perinatal outcome is favorable and justifies expectant management. In the presence of fetal hydrops, perinatal outcome is reported to be extremely poor and intervention should be considered. Therapeutic options include open fetal surgery, minimally invasive coagulation of the blood supply and thoracoamniotic shunting. We present the first case of fetal hydrops and a large hydrothorax due to BPS treated successfully with one ultrasound-guided thin needle insertion, through which both laser coagulation of the feeding artery and drainage of the hydrothorax were performed. Following the procedure the hydrothorax and hydrops gradually disappeared and the BPS diminished in size. A healthy neonate was delivered uneventfully at term. We describe the case and discuss the different therapeutic options.

Entities:  

Mesh:

Year:  2009        PMID: 19681165     DOI: 10.1002/uog.7316

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  3 in total

1.  Fetal lung lesions diagnosis: the crucial role of ultrasonography.

Authors:  Rosa Pedata; Mariarosaria Palermo; Monica Maiello; Nunzia Esposito; Santina Ermito; Angela Dinatale; Sabina Carrara; Alessandro Cavaliere
Journal:  J Prenat Med       Date:  2009-10

Review 2.  Congenital pulmonary malformation in children.

Authors:  Montasser Nadeem; Basil Elnazir; Peter Greally
Journal:  Scientifica (Cairo)       Date:  2012-05-08

3.  Management Options for Fetal Bronchopulmonary Sequestration.

Authors:  Magdalena Litwinska; Ewelina Litwinska; Krzysztof Szaflik; Marzena Debska; Tomasz Szajner; Katarzyna Janiak; Piotr Kaczmarek; Miroslaw Wielgos
Journal:  J Clin Med       Date:  2022-03-20       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.